Cite
HARVARD Citation
Dai, L. et al. (2022). Application of Age, Body Mass Index, Chronic Kidney Disease, Diabetes, and Genotyping Score for Efficacy of Clopidogrel: Secondary Analysis of the CHANCE Trial. Stroke. 53 (2), pp. 465-472. [Online].